Adding-On Wisely: Hematopathology Reflective Testing in Canada.

Eric McEvoy, Eileen R McBride
{"title":"Adding-On Wisely: Hematopathology Reflective Testing in Canada.","authors":"Eric McEvoy, Eileen R McBride","doi":"10.1111/ijlh.70248","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Reflective testing describes laboratory clinicians' discretionary addition of testing on existing samples, after initial result review. This practice has proven valuable in clinical biochemistry but faces controversy regarding consent and costs. No prior research exists regarding reflective testing in Canadian hematopathology. We surveyed hematopathologists across Canada to characterize current practices and perspectives.</p><p><strong>Methods: </strong>A REDCap survey was distributed to 89 licensed hematopathologists across all provinces (excluding Quebec), capturing demographics, institutional guidelines, and reflective testing practices, as well as ethical and medicolegal perspectives. Descriptive statistical analysis was performed on all responses.</p><p><strong>Results: </strong>Thirty-three eligible survey responses were received. Reflective testing was ordered at least once weekly by 63% of hematopathologists, yet only 30% had institutional guidance. Ethical perspectives varied: 27% felt that consenting to initial testing implies consent for reflective testing, while 61% indicated this depends on the type of test added. Routine prior notification of the initial ordering clinician (IOC) and/or patient was reported by only 24%. Overall, 79% supported the use of reflective testing, citing improved diagnostic timeliness, reduced phlebotomy, and patient management. None opposed the use of reflective testing, although 21% had encountered a complaint or legal concern related to the practice.</p><p><strong>Conclusion: </strong>Reflective testing is widely used and supported among Canadian hematopathologists as a value-added practice leveraging clinical expertise to improve patient care. Implementation varies, with diverse institutional guidance and perspectives on implied consent, communication, and medicolegal responsibility. Our findings identify an opportunity for national consensus building to support transparent, ethically grounded, and patient-centered reflective testing practices in hematopathology.</p>","PeriodicalId":94050,"journal":{"name":"International journal of laboratory hematology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of laboratory hematology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1111/ijlh.70248","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Reflective testing describes laboratory clinicians' discretionary addition of testing on existing samples, after initial result review. This practice has proven valuable in clinical biochemistry but faces controversy regarding consent and costs. No prior research exists regarding reflective testing in Canadian hematopathology. We surveyed hematopathologists across Canada to characterize current practices and perspectives.

Methods: A REDCap survey was distributed to 89 licensed hematopathologists across all provinces (excluding Quebec), capturing demographics, institutional guidelines, and reflective testing practices, as well as ethical and medicolegal perspectives. Descriptive statistical analysis was performed on all responses.

Results: Thirty-three eligible survey responses were received. Reflective testing was ordered at least once weekly by 63% of hematopathologists, yet only 30% had institutional guidance. Ethical perspectives varied: 27% felt that consenting to initial testing implies consent for reflective testing, while 61% indicated this depends on the type of test added. Routine prior notification of the initial ordering clinician (IOC) and/or patient was reported by only 24%. Overall, 79% supported the use of reflective testing, citing improved diagnostic timeliness, reduced phlebotomy, and patient management. None opposed the use of reflective testing, although 21% had encountered a complaint or legal concern related to the practice.

Conclusion: Reflective testing is widely used and supported among Canadian hematopathologists as a value-added practice leveraging clinical expertise to improve patient care. Implementation varies, with diverse institutional guidance and perspectives on implied consent, communication, and medicolegal responsibility. Our findings identify an opportunity for national consensus building to support transparent, ethically grounded, and patient-centered reflective testing practices in hematopathology.

明智地补充:血液病反射测试在加拿大。
简介:反思性测试描述了实验室临床医生在初步结果审查后对现有样品的任意添加测试。这种做法已被证明在临床生物化学中是有价值的,但在同意和成本方面存在争议。没有先前的研究存在关于加拿大血液病理学反射测试。我们调查了加拿大各地的血液病理学家,以描述当前的做法和观点。方法:REDCap调查向所有省份(不包括魁北克)的89名有执照的血液病理学家分发,收集人口统计数据、机构指南、反思性测试实践以及伦理和医学法律观点。对所有应答进行描述性统计分析。结果:共收到33份符合要求的调查问卷。63%的血液病理学家每周至少要求进行一次反思测试,但只有30%的人有机构指导。伦理观点各不相同:27%的人认为同意初始测试意味着同意反思测试,而61%的人表示这取决于添加的测试类型。常规事先通知初始订购临床医生(IOC)和/或患者的比例仅为24%。总的来说,79%的人支持使用反射测试,理由是提高了诊断的及时性,减少了静脉切开术和患者管理。没有人反对使用反射测试,尽管21%的人遇到了与实践相关的投诉或法律问题。结论:反思性检测在加拿大血液病理学家中被广泛使用和支持,作为一种增值实践,利用临床专业知识来改善患者护理。执行情况各不相同,在默示同意、沟通和医疗法律责任方面有不同的机构指导和观点。我们的研究结果为全国共识的建立提供了一个机会,以支持透明的、有道德基础的、以患者为中心的血液病理学反射性检测实践。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书